22nd Century Income After Taxes 2011-2024 | XXII
22nd Century income after taxes from 2011 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
22nd Century Annual Income After Taxes
(Millions of US $) |
| 2023 |
$-55 |
| 2022 |
$-37 |
| 2021 |
$-33 |
| 2020 |
$-20 |
| 2019 |
$-27 |
| 2018 |
$-8 |
| 2017 |
$-13 |
| 2016 |
$-12 |
| 2015 |
$-11 |
| 2014 |
$-16 |
| 2013 |
$-26 |
| 2012 |
$-7 |
| 2011 |
$-1 |
| 2010 |
$-1 |
22nd Century Quarterly Income After Taxes
(Millions of US $) |
| 2024-09-30 |
$-4 |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-5 |
| 2023-12-31 |
$-22 |
| 2023-09-30 |
$-8 |
| 2023-06-30 |
$-14 |
| 2023-03-31 |
$-11 |
| 2022-12-31 |
$-3 |
| 2022-09-30 |
$-13 |
| 2022-06-30 |
$-11 |
| 2022-03-31 |
$-9 |
| 2021-12-31 |
$-14 |
| 2021-09-30 |
$-9 |
| 2021-06-30 |
$-4 |
| 2021-03-31 |
$-5 |
| 2020-12-31 |
$-6 |
| 2020-09-30 |
$-4 |
| 2020-06-30 |
$-5 |
| 2020-03-31 |
$-4 |
| 2019-12-31 |
$-6 |
| 2019-09-30 |
$-10 |
| 2019-06-30 |
$-8 |
| 2019-03-31 |
$-2 |
| 2018-12-31 |
$-9 |
| 2018-09-30 |
$6 |
| 2018-06-30 |
$-7 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$-4 |
| 2017-09-30 |
$-3 |
| 2017-06-30 |
$-3 |
| 2017-03-31 |
$-3 |
| 2016-12-31 |
$-3 |
| 2016-09-30 |
$-3 |
| 2016-06-30 |
$-3 |
| 2016-03-31 |
$-3 |
| 2015-12-31 |
$-3 |
| 2015-09-30 |
$-3 |
| 2015-06-30 |
$-1 |
| 2015-03-31 |
$-4 |
| 2014-12-31 |
$-6 |
| 2014-09-30 |
$-3 |
| 2014-06-30 |
$-2 |
| 2014-03-31 |
$-5 |
| 2013-12-31 |
$-8 |
| 2013-09-30 |
$-15 |
| 2013-06-30 |
$-0 |
| 2013-03-31 |
$-3 |
| 2012-12-31 |
$-4 |
| 2012-09-30 |
$-0 |
| 2012-06-30 |
$0 |
| 2012-03-31 |
$-2 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$-0 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.005B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
